199 related articles for article (PubMed ID: 19527762)
1. Using real data for a virtual crossmatch.
Zachary AA; Sholander JT; Houp JA; Leffell MS
Hum Immunol; 2009 Aug; 70(8):574-9. PubMed ID: 19527762
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of solid phase HLA antibody assays for prediction of crossmatch strength.
Ellis TM; Schiller JJ; Roza AM; Cronin DC; Shames BD; Johnson CP
Hum Immunol; 2012 Jul; 73(7):706-10. PubMed ID: 22537747
[TBL] [Abstract][Full Text] [Related]
4. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients.
Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G
Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant.
Claas FH; Doxiadis II
Hum Immunol; 2009 Aug; 70(8):636-9. PubMed ID: 19375467
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
Won DI; Jeong HD; Kim YL; Suh JS
Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
[TBL] [Abstract][Full Text] [Related]
7. Which human leukocyte antigen antibodies are really clinically relevant?
Opelz G; Claas FH
Hum Immunol; 2009 Aug; 70(8):561-2. PubMed ID: 19580832
[No Abstract] [Full Text] [Related]
8. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.
Eng HS; Bennett G; Bardy P; Coghlan P; Russ GR; Coates PT
Hum Immunol; 2009 Aug; 70(8):595-9. PubMed ID: 19527759
[TBL] [Abstract][Full Text] [Related]
9. Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation.
Taylor CJ; Kosmoliaptsis V; Summers DM; Bradley JA
Hum Immunol; 2009 Aug; 70(8):563-8. PubMed ID: 19445992
[TBL] [Abstract][Full Text] [Related]
10. The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients.
Guidicelli G; Anies G; Bachelet T; Dubois V; Moreau JF; Merville P; Couzi L; Taupin JL
Transpl Immunol; 2013 Dec; 29(1-4):17-21. PubMed ID: 24056164
[TBL] [Abstract][Full Text] [Related]
11. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
[TBL] [Abstract][Full Text] [Related]
12. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
13. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.
Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD
Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric detection of complement-activating HLA antibodies.
Schönemann C; Lachmann N; Kiesewetter H; Salama A
Cytometry B Clin Cytom; 2004 Nov; 62(1):39-45. PubMed ID: 15476206
[TBL] [Abstract][Full Text] [Related]
15. Modified solid-phase alloantibody detection for improved crossmatch prediction.
Wahrmann M; Hlavin G; Fischer G; Marinova L; Schwaiger E; Hörl WH; Zlabinger GJ; Körmöczi GF; König F; Böhmig GA
Hum Immunol; 2013 Jan; 74(1):32-40. PubMed ID: 23073293
[TBL] [Abstract][Full Text] [Related]
16. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
17. Donor-specific antibody detection: comparison of single antigen assay and Luminex crossmatches.
Caro-Oleas JL; González-Escribano MF; Toro-Llamas S; Acevedo MJ; Martinez-Bravo MJ; Aguilera I; Núñez-Roldán A
Tissue Antigens; 2010 Nov; 76(5):398-403. PubMed ID: 20630037
[TBL] [Abstract][Full Text] [Related]
18. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?
Gupta A; Iveson V; Varagunam M; Bodger S; Sinnott P; Thuraisingham RC
Transplantation; 2008 Apr; 85(8):1200-4. PubMed ID: 18431242
[TBL] [Abstract][Full Text] [Related]
19. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay.
Vaidya S; Partlow D; Susskind B; Noor M; Barnes T; Gugliuzza K
Transplantation; 2006 Dec; 82(11):1524-8. PubMed ID: 17164726
[TBL] [Abstract][Full Text] [Related]
20. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
